1. Home
  2. LMNR vs ANIK Comparison

LMNR vs ANIK Comparison

Compare LMNR & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$12.78

Market Cap

235.0M

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$20.74

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
ANIK
Founded
1893
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.0M
200.9M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
LMNR
ANIK
Price
$12.78
$20.74
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$20.00
$17.00
AVG Volume (30 Days)
110.1K
81.2K
Earning Date
06-08-2026
04-29-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
$159,723,000.00
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
$13.95
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.67
$8.67
52 Week High
$15.43
$22.88

Technical Indicators

Market Signals
Indicator
LMNR
ANIK
Relative Strength Index (RSI) 38.92 51.92
Support Level $12.56 $20.13
Resistance Level $13.79 $22.70
Average True Range (ATR) 0.47 0.65
MACD -0.20 -0.18
Stochastic Oscillator 17.86 42.48

Price Performance

Historical Comparison
LMNR
ANIK

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: